Nasdaq and S&P 500 Close at Record Highs with Fifth Straight Weekly Gain; Dow Falls
The Nasdaq and S&P 500 ended the trading day at new record highs, marking their fifth consecutive week of gains. The Dow Jones Industrial Average declined. These movements occurred amid reported market-on-close imbalances in major indices.
Wilfredor / Wikimedia (CC BY-SA 4.0)The S&P 500 rose 23.31 points, or 0.32%, to close at 7,232.32, also a record. Both indices logged their fifth straight week of gains.
Market-on-close imbalances showed a buy imbalance of 121 million shares for the S&P 500 and 380 million for the Nasdaq 100. These imbalances reflect final trading activity before the close on May 3, 2026.
The gains in the Nasdaq and S&P 500 extended their positive streak over five weeks. Trading data indicated unofficial closing figures, highlighting the session's mixed results across major U.S. indices.
Key Facts
Story Timeline
3 events- Today — Market Close
Nasdaq and S&P 500 closed at record highs, with Dow declining.
3 sources@FirstSquawk · @MarketWatch - Today — Pre-Close
Market-on-close imbalances reported for major indices.
1 source@financialjuice - End of Week
Nasdaq and S&P 500 logged fifth straight week of gains.
1 source@MarketWatch
Potential Impact
- 01
Record highs in major indices will boost market sentiment for the upcoming week.
- 02
Investors may shift allocations toward tech-heavy indices following the Nasdaq's record close.
- 03
Sell imbalances in Dow and Mag 7 may lead to minor volatility at Monday's open.
Transparency Panel
Related Stories
rte.ieOil Prices Fall More Than 12% on Reports of US-Iran Deal
Reports indicate the United States and Iran are close to a 14-point memorandum of understanding to conclude the ongoing conflict. Oil prices fell sharply after the news emerged before partially recovering following an Iranian announcement. President Donald J. Trump stated that co…
Restaurant Brands International Reports Q1 2026 Earnings
Restaurant Brands International posted first-quarter adjusted earnings per share of 86 cents and revenue of $2.26 billion. Both figures exceeded Wall Street forecasts. Net income attributable to common shareholders reached $338 million.
White House Projects $529 Billion in Potential Savings Over Decade From Trump-Era Drug Pricing Policy
White House economists projected $529 billion in savings over the next decade from agreements President Donald Trump reached with pharmaceutical companies. The analysis also forecasts $64.3 billion in Medicaid savings and up to $733 billion if the framework expands.